Sheela Foam Limited has announced its audited standalone and consolidated financial results for the quarter and year ending March 31, 2026. The Board of Directors, in its meeting held on May 14, 2026, approved and recommended a final dividend of 20%, which is Rs. 1 per equity share of face value Rs. 5 each for the financial year 2025-26. On a consolidated basis, the company reported a revenue of Rs. 1,074.43 Crores for the quarter ended March 31, 2026, compared to Rs. 966.57 Crores in the previous quarter ended December 31, 2025, marking a quarter-on-quarter (QoQ) growth of 11.16%. Compared to the corresponding quarter of the previous year (March 31, 2025), which saw a revenue of Rs. 849.52 Crores, the revenue grew by 26.47% year-on-year (YoY). The consolidated net profit for the current quarter stood at Rs. 52.57 Crores, a significant increase of 211.97% from the previous quarter’s profit of Rs. 16.85 Crores. On a YoY basis, the net profit grew by 140.48% compared to the Rs. 21.86 Crores recorded in the quarter ended March 31, 2025.

Sheela Foam Limited is a prominent leader in India’s mattress and foam products industry, widely recognized for its flagship “Sleepwell” brand and the “Kurl-on” brand. Established in 1971, it is India’s largest manufacturer of flexible slab stock Polyurethane (PU) foam, serving various sectors including automotive, aviation, and footwear. In early 2025, the company focused on achieving synergy benefits from its acquisition of Kurlon Enterprise Ltd (KEL), which expanded its market share to approximately 29% in the modern mattress market and significantly widened its geographic reach across India. Throughout 2025, Sheela Foam continued its strategic growth, completing the merger of several subsidiary companies in January 2026 and resolving fractional share entitlements following the Kurlon arrangement by April 2026. The company also maintains a strategic investment in House of Kieraya (Furlenco), further diversifying its presence in the furniture and comfort sector. Significant institutional investors maintain a strong presence in the company, with notable holdings in 2025-26 from SBI Magnum Midcap Fund (9.78%), Nippon India Multi Cap Fund (2.86%), and SBI Life Insurance (2.00%).